Cargando…
Blocked Autophagy by miR-101 Enhances Osteosarcoma Cell Chemosensitivity In Vitro
The adjuvant chemotherapy, such as cisplatin, doxorubicin, and methotrexate has significantly improved survival of osteosarcoma patients. However, the chemoresistance which arose with the chemotherapy blocks achieving favorable outcomes for some patients and finally led to relapse or metastatic dise...
Autores principales: | Chang, Zhiqiang, Huo, Lifeng, Li, Kun, Wu, Yiming, Hu, Zhenming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072053/ https://www.ncbi.nlm.nih.gov/pubmed/25013866 http://dx.doi.org/10.1155/2014/794756 |
Ejemplares similares
-
miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
por: Xu, Meng, et al.
Publicado: (2014) -
MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin
por: Huang, Nunu, et al.
Publicado: (2015) -
miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy
por: Dong, Suwei, et al.
Publicado: (2019) -
Diagnostic and prognostic implications of serum miR-101 in osteosarcoma
por: Yao, Z.-S., et al.
Publicado: (2018) -
Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma
por: Li, Yunchao, et al.
Publicado: (2016)